Riemser Arzeimittel AG
Country not established
- Devices
- 4
What Riemser Arzeimittel AG makes
Riemser Arzneimittel AG manufactures calcium sulfate-based dental biomaterials, including CERASORB DENTAL, CERASORB M DENTAL, and CERASORB PERIO. These products are designed for bone regeneration and periodontal applications in oral and maxillofacial surgery.
The company’s portfolio is regulated as Class II medical devices in the US, with products listed via the FDA’s 510(k) pathway. The manufacturer is based in the United States.
Catalogue
Cerasorb Plus Ref K120152
Regimes: 510(k) Registry: 510(k)Revois Pro Implant Stsyem Ref K113539
Regimes: 510(k) Registry: 510(k)Revois Implant System Ref K113042
Regimes: 510(k) Registry: 510(k)- Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Riemser Arzeimittel AG have in the registry?
The registry currently lists 4 devices for Riemser Arzeimittel AG. Devices recorded under merged duplicate company entries are counted once.
Which registries list Riemser Arzeimittel AG's devices?
Among its 4 most recently registered devices, Riemser Arzeimittel AG has devices listed in FDA 510(k) (4 devices).
What risk classes do Riemser Arzeimittel AG's devices fall under?
Among its 4 most recently registered devices, the classes recorded for Riemser Arzeimittel AG's devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Riemser Arzeimittel AG in the registry?
The most recently registered devices listed for Riemser Arzeimittel AG include CERASORB PLUS, REVOIS PRO IMPLANT STSYEM, REVOIS IMPLANT SYSTEM and CERASORB DENTAL, CERADORB M DENTAL, CERASORB PERIO.